Co-Authors
This is a "connection" page, showing publications co-authored by Bruno Moulin and Sophie Caillard.
Connection Strength
3.622
-
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone. Transplantation. 2021 10 01; 105(10):2165-2169.
Score: 0.243
-
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
Score: 0.239
-
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021 06; 99(6):1498-1500.
Score: 0.235
-
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021 06; 99(6):1487-1489.
Score: 0.234
-
Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021 03; 21(3):1295-1303.
Score: 0.232
-
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2021 01 01; 105(1):158-169.
Score: 0.230
-
Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol. 2021 01; 28(1):248-258.
Score: 0.227
-
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int. 2020 12; 98(6):1549-1558.
Score: 0.225
-
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. Kidney Int. 2020 08; 98(2):508-509.
Score: 0.221
-
First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant. 2020 Jul; 20(7):1944-1946.
Score: 0.220
-
Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study. Transpl Infect Dis. 2019 Apr; 21(2):e13058.
Score: 0.203
-
Pregnancy in a Kidney Transplant Woman Under Treatment With Eculizumab for Atypical Hemolytic Uremic Syndrome: Is It Safe? Kidney Int Rep. 2019 May; 4(5):733-739.
Score: 0.201
-
Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort. Transplantation. 2018 05; 102(5):860-867.
Score: 0.191
-
Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation. Case Rep Transplant. 2017; 2017:3197042.
Score: 0.187
-
A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1663-1670.
Score: 0.182
-
Global Transplantation COVID Report March 2020. Transplantation. 2020 10; 104(10):1974-1983.
Score: 0.057
-
In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
Score: 0.056
-
Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect. 2019 07; 79(1):56-60.
Score: 0.051
-
The age-calibrated measured glomerular filtration rate improves living kidney donation selection process. Kidney Int. 2018 09; 94(3):616-624.
Score: 0.049
-
The Authors Reply. J Am Soc Nephrol. 2018 05; 29(5):1578.
Score: 0.047
-
Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. J Am Soc Nephrol. 2018 01; 29(1):326-334.
Score: 0.046
-
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017 Jun; 16(6):650-657.
Score: 0.045